Swedencare AB (SWDCF)
2.30
0.00 (0.00%)
USD |
OTCM |
Oct 08, 16:00
Swedencare Profit Margin (Quarterly) : 3.54% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.54% |
| March 31, 2026 | 2.72% |
| December 31, 2025 | 2.40% |
| September 30, 2025 | 3.11% |
| June 30, 2025 | -1.07% |
| March 31, 2025 | 3.73% |
| December 31, 2024 | 3.60% |
| September 30, 2024 | 3.74% |
| June 30, 2024 | 3.31% |
| March 31, 2024 | 5.04% |
| December 31, 2023 | -2.07% |
| September 30, 2023 | 6.33% |
| June 30, 2023 | 2.85% |
| March 31, 2023 | 3.29% |
| December 31, 2022 | 3.17% |
| September 30, 2022 | 0.79% |
| June 30, 2022 | 12.78% |
| March 31, 2022 | 3.89% |
| December 31, 2021 | 7.71% |
| September 30, 2021 | 4.88% |
| June 30, 2021 | 9.50% |
| March 31, 2021 | 6.66% |
| December 31, 2020 | 7.34% |
| Date | Value |
|---|---|
| September 30, 2020 | 20.84% |
| June 30, 2020 | 16.07% |
| March 31, 2020 | 22.37% |
| December 31, 2019 | 16.79% |
| September 30, 2019 | 27.95% |
| June 30, 2019 | 22.42% |
| March 31, 2019 | 27.85% |
| December 31, 2018 | 20.67% |
| September 30, 2018 | 29.00% |
| June 30, 2018 | 22.66% |
| March 31, 2018 | 22.14% |
| December 31, 2017 | 22.78% |
| September 30, 2017 | 20.68% |
| June 30, 2017 | 11.75% |
| March 31, 2017 | 22.85% |
| December 31, 2016 | 4.00% |
| September 30, 2016 | 24.10% |
| June 30, 2016 | 23.61% |
| March 31, 2016 | 23.95% |
| December 31, 2015 | -5.71% |
| September 30, 2015 | 31.81% |
| June 30, 2015 | 34.49% |
| March 31, 2015 | 28.81% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Orexo AB | -2.93K% |
| Camurus AB | 34.30% |
| Moberg Pharma AB | -56.91% |
| Infant Bacterial Therapeutics AB | -- |
| AstraZeneca PLC | 20.15% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 1.17% |
| Return on Assets | 0.83% |
| Return on Invested Capital | 0.93% |
| Gross Profit Margin (Quarterly) | 7.63% |
| Operating Margin (Quarterly) | 7.63% |
| Return on Net Operating Assets | 0.87% |